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Abstract
Background: Bhutan has achieved a major reduction in malaria incidence amid multiple challenges. This case
study seeks to characterize the Bhutan malaria control programme over the last 10 years.
Methods: A review of the malaria epidemiology, control strategies, and elimination strategies employed in Bhutan
was carried out through a literature review of peer-reviewed and grey national and international literature with the
addition of reviewing the surveillance and vector control records of the Bhutan Vector-Borne Disease Control
Programme (VDCP). Data triangulation was used to identify trends in epidemiology and key strategies and
interventions through analysis of the VDCP surveillance and programme records and the literature review. Enabling
and challenging factors were identified through analysis of socio-economic and health indicators, corroborated
through a review of national and international reports and peer-review articles.
Findings: Confirmed malaria cases in Bhutan declined by 98.7% from 1994 to 2010. The majority of indigenous cases
were due to Plasmodium vivax (59.9%) and adult males are most at-risk of malaria. Imported cases, or those in foreign
nationals, varied over the years, reaching 21.8% of all confirmed cases in 2006.
Strategies implemented by the VDCP are likely to be related to the decline in cases over the last 10 years. Access
to malaria diagnosis in treatment was expanded throughout the country and evidence-based case management,
including the introduction of artemisinin-based combination therapy (ACT) for P. falciparum, increasing coverage of
high risk areas with Indoor Residual Spraying, insecticide-treated bed nets, and long-lasting insecticidal nets are
likely to have contributed to the decline alongside enabling factors such as economic development and increasing
access to health services.
Conclusion: Bhutan has made significant strides towards elimination and has adopted a goal of national elimination.
A major challenge in the future will be prevention and management of imported malaria infections from neighbouring
Indian states. Bhutan plans to implement screening at border points to prevent importation of malaria and to targeted
prevention and surveillance efforts towards at-risk Bhutanese and migrant workers in construction sites.
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Background
In recent years, there has been substantial progress made
in reducing the malaria burden around the globe [1,2].
From the deep Amazon and the coastal plains of East
Africa to the Malaysian peninsula, incidence has been
decreasing over the last decade, related to increased
resources for malaria control and better access to new and
improved tools [3,4]. The South-East Asia region has
some of the most pronounced declines, with five countries
out of 11 reporting decreases of more than 50% of cases
from 2000 to 2009 [2]. One of these success stories is
tucked away, high up in the eastern Himalayas: Bhutan
has achieved remarkable success in bringing down malaria
transmission and announced a national strategy to elimi-
nate malaria by 2016.
The progress made in Bhutan in the last 10 years is
remarkable given the major challenges it faces. The
country is placed in some of the most difficult terrain in
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the region, where landslides create impassible roads in
the monsoon months and where 21% of households are
located more than 4 h walk from the nearest road [5].
The low-lying southern region of Bhutan is at high-risk
for malaria transmission [6] and has a highly porous
border with India, through which there is significant
population movement. In addition, large numbers of
migrant workers enter the country to work in large-
scale development projects in areas vulnerable to
malaria transmission, creating a risk of continual impor-
tation and re-introduction of malaria into the area [7].
Given these and other challenges, the recent success in
reducing malaria incidence may contain lessons for
other countries [8].
This paper seeks to characterize the malaria programme
of Bhutan over the last 10 years, exploring trends in the
epidemiology of malaria, malaria control strategies and
interventions, and the enabling and challenging conditions
of Bhutan with emphasis on the endemic southern border
and population migration.
Methods
Geography, population and climate
The Royal Government of Bhutan is a small country,
spanning 38,394 km2, with a population of 677,343 bor-
dered in the north by the Tibetan Region of China, and by
India to the west, south and east with the states of Sikkim,
West Bengal, Assam, and Arunachal Pradesh, respectively.
The country is mainly mountainous, rising to a maximum
elevation of 7,314 m and extending down to as low as
160 m above mean sea level in the southern foothills.
Bhutan’s economy is based on agriculture, forestry, and
hydropower electricity exports to India [9,10].
Bhutan has seasonal rainfall with monsoon rains occur-
ring from June to September, when most malaria cases
occur [11]. A winter northeast monsoon occurs from
November to March, with snowfall in the higher eleva-
tions. Bhutan has only 2.3% arable land, most of which is
in the west [10].
Malaria risk areas are mainly forest and forest-fringe
human settlements, in particular those with irrigation or
development projects, such as hydropower project sites
[5]. Twenty-four percent of the population lives in areas
considered free of malaria, located in four districts in the
north-east and central part of the country (Figure 1) [12].
These areas are not receptive to malaria transmission due
to their high elevation and cooler temperatures. Indigen-
ous cases reported from these districts are imported cases
from other districts. Nine districts in a band running east
to west across the center of the country are considered at
risk for seasonal transmission, having a history of local
transmission although some of them have not had an indi-
genous case in the last 3 years. This zone contains 34% of
the population. Seven districts, with a population of
284,512 (42% of the total population), are considered
malaria-endemic, where transmission occurs throughout
the year [11]. These districts border the Indian states of
Assam and West Bengal.
Programme data
A literature review was conducted using PubMed, Google
Scholar, Google, SpringerLink, [13] World Health
Figure 1 Prevalence of malaria in Bhutan. Districts in purple are malaria-free, districts in green are considered at risk for seasonal transmission,
districts in brown are considered malaria-endemic.
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Organization (WHO) South-East Asia Region Institu-
tional Repository, [14] World Health Organization
Library Database (WHOLIS), [15] and through requests
to the WHO Archives at the WHO Headquarters in
Switzerland. Search terms were “Bhutan” AND “malaria”
OR “prevention” OR “refugee” OR “Nepal” OR “India”
OR “supply, supply system” OR “health system” OR
“health supply.”
Routine national health facility surveillance data were
collected and reviewed in-country by two researchers (TY
and CSG), for indigenous (cases contracted locally) and
imported cases [16]. In Bhutan, an imported case is a con-
firmed malaria infection in any foreign national. The
reported cases described in this study were confirmed by
microscopy. Reporting of presumptive cases is not the pol-
icy in Bhutan and rapid diagnostic test (RDT) results are
cross checked by microscopy. Results of the microscopy
confirmation process are reported, not the RDT results.
These secondary data were collected from the Vector-
borne Disease Control Programme (VDCP) headquarters
in Gelephu, which receives and compiles reports of con-
firmed cases from the districts. Other data collected were
VDCP-derived estimates of population at risk and distri-
bution and coverage of long-lasting insecticidal net
(LLIN), insecticide-treated bed nets (ITN), and Indoor
Residual Spray (IRS). Annual rainfall data were collected
by the VDCP for the period 1996-2010 for 18 districts.
When discrepancies between any of the data sources were
found, follow-up information was sought from district
offices by the VDCP programme manager (TY).
Data analysis
Surveillance and vector control data were plotted using
Microsoft Excel and trends were observed. These trends
were then compared with those described in the literature
identified in the review and with information provided by
the VDCP headquarters and district officers, using data
triangulation to identify and confirm trends [17]. The
WHO World Malaria Report surveillance data were used
to corroborate the VDCP data records.
Ethical considerations
The Ministry of Health in Bhutan approved the conduct of
the case study. Data from the Ministry of Health, Vector-




The literature review identified 35 peer-review publica-
tions, 28 WHO reports and documents, ten reports by
other partners and agencies, and 20 published or grey
reports from Bhutanese ministries including three
reports from the Ministry of Health. A list of these
documents is shown in the online web appendix (Addi-
tional file 1) [18]. These documents provided program-
matic information and corroborated the findings of the
data analysis. The Malaria Programme Reviews, con-
ducted in collaboration with WHO by the VDCP in
2007 and 2010, were key sources for this case study
[12,19].
Programme structure
The VDCP of Bhutan coordinates and ensures the capa-
city of the district health teams to carry out prevention
of malaria and other vector-borne diseases, namely den-
gue, kala-azar and Japanese encephalitis. The VDCP
relies upon the structure of the national health system
of Bhutan to provide the integral components of malaria
surveillance, case management, and prevention through
an integrated community health approach [20]. The
national primary health care system is comprised of
national and regional referral hospitals, district hospitals,
Basic Health Units (BHUs) and Outreach Clinics (ORC).
Outreach clinics conduct antenatal check-ups and
immunizations, but do not play a major role in malaria
control.
The service delivery structure of the VDCP is based
upon multipurpose malaria health workers, termed
malaria technicians, that are deployed by the VDCP to
hospitals, and in the endemic southern districts, BHUs as
well [12]. These health workers, whose salary is paid by
the Ministry of Health, work only on malaria and provide
a wide range of services including reading blood slides for
malaria diagnosis, issuing treatment, case reporting, and
case follow-up. They also support IRS and LLIN distribu-
tion, entomological surveillance, and Information Educa-
tion and Communication (IEC) activities. Health
assistants, nurses and doctors provide the malaria treat-
ment. Village health workers help in executing IEC activ-
ities. Spray operators conduct the IRS coordinated by the
malaria technicians.
The role of malaria technicians has begun to be inte-
grated with other vector-borne diseases beyond malaria
control, and a new title has been assigned–"Medical Tech-
nicians.” In the future it is expected that the role of
Malaria Technicians will increasingly become integrated
and their main activities may change, posing a risk of
diminishing vigilance for malaria as other diseases become
a greater priority. However, as of yet, only a portion of
them received the integration training and many are still
referred to as “Malaria Technicians”.
Domestic resources, through tax and non-tax revenue of
the Government of Bhutan, account for two-thirds of total
health-related expenditures in Bhutan, and external finan-
cing accounts for approximately one-third [21]. The Royal
Government of Bhutan has provided an increasing amount
of support to the VDCP over the last 5 years, contributing
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21.5% of the total VDCP budget over the period 2009-
2010. The total VDCP budget was $445,950 USD in 2009-
2010, which included malaria and other vector-borne dis-
eases. Government support to district malaria-related
expenditures are not included in this figure.
The Government of India, a long-time partner of the
Royal Government of Bhutan, has contributed USD
$177,777 annually, which is mainly used to procure insec-
ticides for Bhutan’s IRS programme. This collaboration
has continued since the 1960s. Approved Global Fund to
Fight AIDS, Tuberculosis and Malaria (Global Fund) grant
amounts were $1,737,190 (Round 4, funding received
starting in 2005) and $2,662,468 (Round 7, funding began
2008) [22]. In addition, the World Health Organization
(WHO) and other partners have provided technical assis-
tance and some financial support. Out of ten countries in
the South-East Asia region, Bhutan ranks the highest in
cumulative per person availability of donor funding, at
$10.75 USD per capita [22].
Epidemiology of malaria
Locally contracted or indigenous cases
In 2010, there were 436 microscopy-confirmed indigenous
cases. Of these, 261 (59.9%) were due to Plasmodium
vivax, 140 (32.1%) were due to Plasmodium falciparum,
and 35 (8.0%) were mixed infections. The total number of
cases in 2010 is similar to the 518 cases reported in 1965
(see Figure 2) [11]. All reported cases are confirmed by
microscopy, even if the initial diagnosis was by RDT. Biva-
lent RDTs to detect both P. falciparum and P. vivax were
introduced in 2006.
The highest peak of malaria cases occurred in 1994, with
nearly 40,000 indigenous cases. A major decline of 85.1%
occurred from 1994 (39,852 cases) to 2000 (5,935) that
continued until 2010 (436 cases). A small increase in cases
occurred from 2008 (329) to 2009 (972), which was asso-
ciated with the early arrival of the monsoon rains or the
loss of efficacy of LLINs distributed in 2006 after a lapse
of 3 years [23]. The Annual Blood Examination Rate
(ABER), or the number of blood slides examined for
malaria parasites as a proportion of the total population at
risk, varied over the years with no clear trend and ranged
between 9.7% (2008) and 20.9% (2010).
The proportion of indigenous cases resulting from
P. vivax infections, as compared to those identified as
P. falciparum or mixed infections (both P. falciparum
and P. vivax), has ranged from a low of 42.5% (2009) to
a high of 59.9% (2010). Mixed infections in Bhutanese
have nearly doubled from 2001 to 2010, from 4.4 to
8.0%, respectively. This increase may be related to
improvement in diagnostic specificity and is less likely
to reflect an increase in transmission intensity of mixed
infections.
Males, specifically male farmers and students between
the ages of 15-49 years, are the population groups at
highest malaria risk [24]. This is most likely due to var-
ious occupational factors, such as forest work, firewood
collection, guarding fields at night, or travel to India for
business [8,12].
Imported cases
The proportion of total cases (indigenous and imported)
considered imported, or those found in foreign nationals,
varied greatly over the years, reaching a high of 408
imported cases in 2006, representing 21.8% of all con-
firmed cases (Figure 3). In 2010, 28 cases were considered
to be imported (6.0% of total confirmed cases).
Figure 2 Malaria cases in Bhutan, 1965-2010.
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Imported cases have a slightly higher proportion of
P. falciparum infections: in 2010, 46.4% of all imported
infections were due to P. falciparum in contrast to 32.1%
of indigenous cases. Similar to the increasing trend found
in indigenous cases, mixed infections in imported cases
appear to be increasing and represented 17.9% of infec-
tions in 2010.
Sarpang District, which borders Assam State of India,
recorded the majority of imported cases (every year from
2000 to 2010) and the highest number of indigenous cases
in 7 out of 10 years (2000-03, 2005, 2008-10). Over the
last decade, this district has contributed an average of
87.5% of imported cases and an average of 47.1% of indi-
genous cases in Bhutan. The border is highly porous,
exemplified by the many residents of neighboring Assam
receiving treatment in the district’s health clinics. In 2009
there was a reported outbreak of malaria in Assam with a
26.8% increase in reported cases [23]. This trend was mir-
rored in Sarpang, where a three-fold increase was reported
that same year (Figure 4). Eighty percent of infections that
year were due to P. falciparum. Rainfall trends from 2000
to 2010 from Bhur Station in Sarpang District indicate
that there was no clear trend in rainfall in this district over
this period (Figure 4) [25].
Vectors
In the past, Anopheles minimus was incriminated in trans-
mitting malaria in Bhutan and it was presumed that Ano-
pheles fluviatilis and Anopheles dirus were also important
vectors (See Panel 1) [26]. However, none of these species
have been recorded in the last 10 years. While Anopheles
minimus and Anopheles fluviatilis have been found
recently in eastern Bhutan (Bhutan VDCP), Anopheles
pseudowillmori and Anopheles culicifacies are suspected to
be the main vectors because of their behaviour (both endo
and exo-phagic and anthropophillic) and their relative
abundance during the peak transmission season. Both spe-
cies in high densities have been found to bite cattle
between 18:00-20:00 h. Species composition studies
undertaken in Bhutan on Anopheles culicifacies found spe-
cies B and C; C is not considered a vector, but B is a pro-
ven malaria vector in India [26]. Anopheles culicifacies are
rarely found indoors in the presence of two rounds of IRS
per year and LLIN coverage. Current studies have still
failed to incriminate any vectors in Bhutan. Training for
sibling-species composition, host-blood meal analyses and
techniques for sporozoite infectivity are needed to inform
vector control interventions [12] (see Table 1).
Surveillance
Malaria is a notifiable disease in Bhutan, with microscopy-
confirmed cases reported on a weekly basis. As private
sector health practice in Bhutan is minimal, malaria
under-reporting from this sector is considered negligible
[2]. There is a functioning quality control system for
microscopy in malaria-endemic areas; compulsory
monthly blood film cross-checking is conducted by the
VDCP. In at risk seasonal transmission and malaria-free
areas, staff members send slides to the VDCP for cross-
checking on a quarterly basis. 10% of negative and 50% of
all positive slides are cross-checked for accuracy and qual-
ity. Malaria microscopy training is ordered if there are
false positive or negative rates beyond the acceptable limit.
A significant challenge is that blood films are sent by post
and are sometimes broken and un-readable upon arrival.
Vertical reporting occurs each week wherein reports
flow from health facilities to the districts, then to the
VDCP [12]. Reports are submitted to the Bhutan informa-
tion system of the Ministry of Health each quarter.
Reporting is supervised by on-site data verification during
monitoring and supervision visits to the health centers. In
addition, the VDCP checks with individual centers by
phone if there are missing or incomplete reports. The
VDCP analyses the weekly and monthly reports and, if an
increase in cases is reported, the respective health center is
Figure 3 Confirmed cases in Bhutan, 2000-2010.
Figure 4 Confirmed cases in Sarpang District, indigenous and
imported cases, 2000-2010, with total annual rainfall in
Sarpang District [25].
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alerted and vector and case surveillance investigation and
Information, Education and Communication (IEC) activ-
ities are carried out to locate the source of transmission
and implement containment strategies, including IRS in
the cases where the area has not been sprayed the two
rounds that year [24]. Mass screening of fever cases is also
conducted within the affected locality (no fixed radius). A
team from the VDCP, accompanied by the Malaria Tech-
nician from the respective health center, conducts this
investigation. Often times a report of an outbreak will
reach the Health Minister.
Passive case detection (PCD) is the main method of
parasitological surveillance in Bhutan. Despite the chal-
lenges of rugged terrain, health facilities with microscopy
testing are available at the national, regional, and district
levels. BHUs at the community level provide the bulk of
malaria diagnosis using microscopy, using RDTs in the
rare instances where microscopy is not available [11]. The
Global Fund supported the introduction of these bivalent
(P. falciparum and P. vivax) RDTs in 2006, and since that
time 9,744 RDTs have been delivered to Bhutan [2]. These
RDTs, if all were used (and most were used in emergen-
cies only), represent a small portion of the total malaria
tests (180,156) conducted over that time period. Back-up
blood smears taken from all RDT-confirmed patients are
sent to the VDCP to be tested [24]. The policy in Bhutan
is to give treatment according to the RDT result in the
case of RDT-testing, before confirmation of the blood
smear. However, only the results of microscopy confirma-
tion are reported.
The number of blood films collected in health facilities
has declined over the past 10 years by 28.0%, with 55,046
films collected in 2010. In 2010 the ABER was 20.9%. This
decline is in accord with the decline in malaria cases.
Blood films collected from non-nationals varied over the
last 10 years, and in 2010 there were 7,624 blood films col-
lected from non-nationals.
Proactive case detection (ACD), or household malaria
screening of those with fever by surveillance workers, was
conducted in Bhutan in the 1960s and 1970s, but has not
been employed since that time. The elimination strategy,
beginning in 2010, calls for the reintroduction of monthly
proactive ACD, or focal screening and treatment by
mobile clinics, with the aim to eliminate parasite reser-
voirs. These clinics would be implemented by the BHUs,
carried out by village health workers or volunteers, as they
are located in the risk areas. Malaria screening does not
occur in antenatal clinics.
Malaria control strategies and interventions
Prevention and vector control
The major prevention and vector control interventions in
Bhutan are IRS, ITNs, and LLINs. Larviciding and envir-
onmental management have been explored only through
small-scale projects. Up until 1998, IRS was the main
method of vector control, applied in malaria-endemic
southern districts every 6 months with a goal of universal
coverage. IRS is not conducted in other areas besides
these southern districts. From 1998 to 2004, however, IRS
was halted as ITN distribution became the main control
tool. In 2004, IRS was re-introduced using new stratifica-
tion criteria. Targeted spraying was employed according to
these criteria, which were areas with confirmed malaria
cases, P. falciparum rate above 5%, Slide Positivity Rate
(SPR) above 3%, Annual Parasite Index (API) above five
cases per 1,000 population, and presence of malaria deaths
within the past 3 years. No IRS was used in the areas at
risk for seasonal transmission in the interior. In 2006,
LLINs were introduced alongside the continuation of focal
IRS. From 2011 onwards, taking into account major
reductions in caseload, the stratification thresholds for
deployment of IRS became more stringent, to an SPR
above 2% and an API above 4 per 1,000 population. Vector
prevalence, vector behavior, and proximity to populations
along and across the border were introduced as additional
stratification criteria for use of IRS. Focal IRS is carried
out in villages that do not meet the IRS stratification cri-
teria. Focal IRS consists of spraying households within a
one-kilometer radius of an indigenous case when reported.
A Malaria Indicator Survey (MIS), which contained a
Knowledge, Attitudes and Practices (KAP) component,
was conducted in 2009 and found that 57% of respondents
in the survey felt that “IRS did help in controlling the
number of mosquitoes” but that many believed that “IRS
effects were short-lived” [27]. 87% of households preferred
using a bed net to IRS.
VDCP records indicate that population coverage of IRS,
measured by the number of households sprayed out of the
number of households targeted specifically for IRS, was on
average 97.8% over the period 2004 to 2009. The WHO
programme review similarly reports IRS coverage as “over
90%”[12]. However, population coverage estimated by the
number of persons covered by IRS out of the estimated
population at risk by district indicates a lower level of cov-
erage. An average of 36.1% of the population at risk
received IRS from 2004 to 2009. In 2009 coverage per per-
son at risk peaked at 50.9%.
Table 1 Anopheles fauna in Bhutan [26]
Plains: An. pseudowillmori, An. vagus, An. subpictus, An. culicifacies, An. jamesii, An. pseudojamesii, An. annularis, An. philippinensis, An. kochi, An.
peditaeniatus, An. acinitus, An. barbirustris, An. barbumbrosus, An.umbrosus
Mountains: An. maculatus, An. willmori, An. lindesayii, An. baileyii, An. aitkenii and An. bengalensis
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The Government of India has supported procurement of
insecticides for the Bhutan VDCP since the 1960s. DDT
(dichlorodiphenyltrichloroethane) for IRS was introduced
in 1962 as part of the malaria eradication programme, and
its application might have eliminated the primary vector,
An. minimus [28]. DDT use was halted in 1995 with grow-
ing evidence of resistance in Anopheles maculatus. As a
result, deltamethrin, a synthetic pyrethroid, was intro-
duced for IRS and for the impregnation of mosquito nets
[28]. In 2008, cyfluthrin was introduced for IRS because
the VDCP could not procure adequate supplies of
deltamethrin.
ITN distribution began in 1998 [29]. By the end of 2008,
an estimated 90% coverage was reached in endemic areas,
with two rounds annually of treatment in endemic areas
and one round in epidemic areas [19]. In 2006, LLIN dis-
tribution began, with support from the Global Fund.
LLINs were sent to the health centers which in turn dis-
tributed to households. While the majority of LLINs were
sent to the endemic southern districts, more than 20,000
LLINs were sent to areas throughout the country consid-
ered “hard-to-reach,” or more than 3 h walking distance
from the nearest health center or BHU.
A total of 228,053 LLIN were distributed from 2006 to
2010. In 2010, coverage of households specifically targeted
for LLIN was 96.9%, and a household survey in 2009
found that 82.5% had at least one LLIN [27]. However,
when calculating 2010 coverage as the number of people
protected out of the total population at risk, 77.2% of the
risk population in the endemic, southern districts were
protected by LLINs (assuming LLINs were appropriately
used, provided protection for two people, and were effec-
tive for at least 3 years). Appropriate utilization rates of
both ITNs and LLINs are estimated to be 90.1% [27].
Entomological surveillance is implemented in the ende-
mic, southern districts and this includes vector population
monitoring. Vector density studies, bio-assay tests on
LLINs and susceptibility tests are conducted on a monthly
basis. Insecticide resistance monitoring is conducted
through three sentinel sites in Sarpang District, the border
district with the highest number of cases. The elimination
programme calls for the expansion of insecticide resistance
studies to the areas in the interior at risk for seasonal
transmission.
Treatment and prophylaxis
Plasmodium vivax infections in adults were treated with
chloroquine up until 2005, when the treatment policy
changed to use of primaquine (0.25 mg/kg) for 14 days
and chloroquine (25 mg/kg for adults) in divided dose
over 3 days. This primaquine dose is considered effective
by the VDCP, although WHO guidelines suggest that in
Southeast Asia higher doses are required [30]. A 2010
review of P. vivax treatment suggested that 0.375 mg/kg
base weight is the minimum dosage to eliminate
hypnozoites [31]. However, the dose has not been
increased because of the risk posed to G6PD-deficient
individuals. There is no point of care test for this blood
disorder to use before treatment in Bhutan. Patients take
this treatment at home, without observation, and are
asked to report any signs indicating hemolysis. To date,
there have been no reports of adverse events to the Drug
Regulatory Authority regarding primaquine treatment.
There are also no reports available on concerns by health
workers or patients relating to use of primaquine. Treat-
ment for uncomplicated P. falciparum infections from
2000 onward consisted of artesunate (3 days) with doxycy-
cline (7 days) for adults. Artemisinin-combination therapy
(ACT) was introduced in 2006 (artemether-lumefantrine).
From July 2011 revised guidelines include the administra-
tion of a single dose of primaquine (0.75 mg/kg) as an
anti-gametocyte for P. falciparum infection, without prior
G6PD testing. Adult patients with mixed parasite infec-
tions receive artemether-lumefantrine (24 tablets) with
primaquine (15 mg) daily for 14 days for radical cure of P.
vivax. Malaria chemoprophylaxis is not recommended in
Bhutan.
Severe and complicated P. falciparum infections receive
artemether (3.7 mg/kg) intramuscular injection upon
admission, then injections (1.6 mg/kg) once a day followed
by a full course of artemisinin-combination treatment
(ACT) with artemether-lumefantrine (AL) when able to
tolerate oral medicines. Alternatively, intravenous admin-
istration of quinine followed by oral doses is given.
Three-day compulsory admittance to hospital is applied
to all P. falciparum infections and patients receive directly
observed therapy, with a blood slide conducted each day.
Patients are then advised during discharge to return for a
repeat blood slide examination after 3 days. If the patient
does not return the Malaria Technician retrieves a blood
slide from this person at least once. Post-treatment follow-
up of P. falciparum cases started with Global Fund Round
4 support, but was already in practice in health centers in
some endemic districts. Case follow-up of P. falciparum
cases is now mandatory, including case investigation with
monitoring of vector breeding sites conducted by BHU
staff. A report form is used for this investigation, capturing
information on patient travel history, reported adherence
to treatment, household residents, LLIN condition, IRS
coverage, and potential breeding sites. Twenty-eight day
follow-up of P. vivax infections to measure treatment
adherence and efficacy is planned but not yet introduced.
Since 1984 drug efficacy monitoring for the most part
has focused on treatment of P. falciparum. In 2006, five
sentinel sites were established in endemic districts to
monitor drug resistance to ACT, and the efforts were
further boosted by Global Fund support (Round 7). The
ACT AL has been shown to be 100% efficacious for
the treatment of P. falciparum, according to the VDCP.
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The elimination strategic plan calls for therapeutic efficacy
studies of P. vivax treatment.
Enabling and challenging conditions in malaria control
and elimination
In addition to the national programme strategies and
interventions developed and implemented to control
and eliminate malaria, there are also environmental and
socio-economic factors that can directly impact malaria
transmission. These factors are considered below.
Enabling conditions
Bhutan has made major advances in economic develop-
ment in the last decade. Gross National Income (GNI) per
capita nearly tripled from 2000 and 2009, from $730 to
$2,030 (current USD, Atlas Method), the latter figure
being the highest GNI per capita in South Asia [21]. Road
length increased by 43% from 2001 (3,746 km) to 2008
(5,363 km). Tourism revenue more than quadrupled dur-
ing the same period ($9.2 million USD to 38.8 million).
In addition to economic advances, Bhutan has strength-
ened its health system and offers free health services for
all. The WHO awarded the country its 50th anniversary
award for primary health care in 1998, referring to its sys-
tem as “one of the best in South-East Asia” [32]. The
country’s elimination agenda benefits from a stronger
health system than exists in most lower-middle income
countries. Bhutan is currently one of the leading countries
in per capita expenditure on health, on par with Sri Lanka,
spending up to $75 per capita (current USD) [21].
From 2000 to 2009, there was a 61% increase (109-176)
in the number of physicians in the national health system
[33]. There was also an increase in births attended by
trained personnel, from 24% in 2005 to 66.3% in 2008
[34]. The malaria programme also benefits from a strong
national supply and logistics system: for example, there
were no reported anti-malarial drug stock-outs in recent
years [12]. District and sub-district health facilities coordi-
nate movement of supplies to avoid stock-outs.
Bhutan’s health services are nearly all provided by the
public sector. There are no private medical facilities and
only a handful of retail pharmacy shops [12,35]. As a
result, the government has a high level of control of case
management and malaria control measures.
Challenging factors
Rugged terrain and remote, hard-to-access population
groups create challenges in access to healthcare facilities.
The majority of the population (69.1%) live in rural areas
[5]. As stated above, 21% of the population are considered
“difficult to access” in that they are located more than 4 h
walk from the nearest road. Access is further impeded by
rain, landslides and road closures during the major mon-
soon season, which is also the peak season of malaria
transmission. Delays in treatment have been associated
with remoteness and the cost of transportation to health
facilities [35]. In addition, there is a strong tradition of tra-
ditional medicine in Bhutan whose practice can delay
prompt and correct malaria treatment [35].
Although, over the last decade there have been recent
improvements in the number of staff available in the
national health system, historically there have been
shortages of highly trained workers as a result of the
limited training institutions located in Bhutan. There is
no medical college and physicians and most technical
professions are trained abroad [8,21].
While the socio-economic development taking place in
Bhutan may play a role in reducing the receptivity to
malaria transmission, there are major development pro-
jects underway that could undermine those advances.
Major construction of hydropower dams and other pro-
jects may expand vector-breeding habitats and have led to
large influxes of migrant workers, typically from malaria
endemic regions of India and Bangladesh, thereby increas-
ing the risk of importation of malaria and onward trans-
mission. There are an estimated 35,000 documented
migrant workers in Bhutan, the majority of which are
employed in large-scale development projects in the inter-
ior and southern districts. While a recent cross sectional
survey conducted in two hydroelectric plant construction
sites indicated a low level of parasitaemia in worker
groups, the overall risk posed by these migrants is not
known [36]. The majority of workers surveyed were from
the Indian states of West Bengal, Bihar, Jharkhand, and
Uttar Pradesh [36]. Outside of migrant labor, further
population movement results from the national resettle-
ment programme, which relocates Bhutanese from low
transmission areas to endemic areas to increase access to
arable land. These resettled populations may both lack
malaria immunity and knowledge about the disease and its
prevention and treatment [35].
Thirdly, there have been recent short and long-term
changes in climate and rainfall, which are thought to have
contributed to the increase in incidence in 2009 [12]. Cli-
mate-related severe weather patterns have been observed,
and increasing temperatures and changes in rainfall are
predicted to have major health impacts [37].
Lastly, and perhaps the greatest threat to a successful
elimination plan, is the border with Assam State of India.
The porous border is malaria-endemic, largely composed
of forest reserve, and is characterized by historical politi-
cal instability, transient and semi-permanent settlements,
mobile populations, and impoverished conditions. There
are virtually no malaria surveillance or referral services,
apart from non-governmental organizations (NGOs)
based in the area [23]. As a result, Assam population
groups often migrate into Bhutan seeking healthcare ser-
vices, in particular at Sarpang District Hospital. Other
migrant groups include daily contractual workers and
casual laborers. There is an estimated daily migration of
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1,000 people entering Bhutan through each regulated
checkpoint in ten border towns. It is unknown how
many migrants pass through unregulated areas of the
border, and as these populations have not been studied,
there are no certain estimates of cross border movement.
A clearer understanding of the migration pathways into
and within Bhutan would help in targeting interventions
to prevent importation of malaria.
Elimination strategy
The decision to pursue malaria elimination in Bhutan,
which aims to eliminate first in the interior of the country
and progressively work toward the southern border areas,
was shaped by sustained low malaria incidence in the
interior of the country over the last 10 years. In most of
this area there have been no indigenous cases of malaria
in 3 years, with few imported from the border districts. In
addition, the epidemiological, technical and programmatic
assessment of the malaria programme review, conducted
in March 2010 in collaboration with WHO, supported the
decision to pursue elimination [12]. Progress made in
the South-East Asia region, such as recent successes in
Sri Lanka and Thailand, also influenced the decision to
eliminate [38].
Progressive malaria elimination in Bhutan will require
intensified efforts in case-based surveillance, with rapid
notification, case investigation and case containment stra-
tegies. The expansion of parasitological and entomological
surveillance is a priority, and must include the identifica-
tion and mapping of local malaria foci, which is dependent
upon the creation of district-level case investigation and
rapid response teams. The expansion of outreach clinics,
typically used for vaccination and antenatal activities, to
include malaria PCD and methods of ACD will enhance
surveillance in remote areas. Case management policies
will also be strengthened–case follow-up for one month
for P. falciparum infections is planned, and a 14-day fol-
low-up period for P. vivax. Case-based IRS, when indigen-
ous cases are found, is planned to be implemented in the
interior districts, where IRS has not yet been employed.
A cross-border malaria strategy with India has been
identified as a necessary next step in order to achieve elim-
ination in Bhutan. Over the years, several efforts were
made to establish cross-border mechanisms for Bhutan
and India to improve malaria control, surveillance, infor-
mation sharing and research along the border zone. In the
early years of the malaria programme, in the 1960s, IRS
activities were synchronized along the border. In the mid-
1990s, WHO supported meetings between the countries
seeking to improve information-sharing through study
tours, conduct joint training and strengthen entomological
surveillance. However, these activities were not sustained.
In 2000, the USAID Bureau for Asia and the Near
East (ANE) and USAID Nepal, in collaboration with
WHO, supported a regional initiative of Bangladesh,
Bhutan, India, and Nepal (BBIN) to implement cross-
border activities for control of malaria, leishmaniasis,
and Japanese encephalitis. The goal was to support the
development of new interventions, expansion of proven
interventions, and to improve surveillance programmes.
Guidelines for surveillance, research studies, an IEC
national programme, and a surveillance system were
developed for Bhutan. The BBIN project was eventually
disbanded due to a reduction in funding.
The current elimination strategy focuses mainly on
management of imported malaria. Six border malaria
screening centers will be installed at security check-
points in five districts. The planned border malaria
screening and LLIN distribution will target both at-risk
Bhutanese and migrant workers in construction sites.
Discussion
Bhutan has achieved a 98.7% decrease in microscopy-con-
firmed malaria cases from 1994 to 2010. Declines occurred
in the zone at risk for seasonal transmission in the interior
of the country as well as in the endemic, southern border
districts [24]. In 2004, Bhutan met and surpassed the
Millennium Development Goals set by RBM, achieving
over 50% reduction in cases well ahead of the 2010 goal.
Stemming from this success, and building on the strengths
of the national health system and the Vector-borne Dis-
ease Control Programme, Bhutan is embarking on malaria
elimination.
The evidence-based strategies implemented by the
VDCP are likely the root of Bhutan’s malaria success,
along with the economic and social development seen in
the country. The programme benefits from a strong pri-
mary health care system and continually expanding access
to health care, including malaria diagnosis and treatment,
at the district and sub-district levels in rural and remote
areas. A well-functioning health supply system allows few
stock-outs. As a result of these improvements, access to
timely diagnosis and treatment through PCD has likely
improved, with weekly case reporting linking epidemiolo-
gical trends to vector control measures. Evidence-based
case management policies, including the implementation
of ACT for P. falciparum cases, may have also contributed
to the declining transmission [24].
The deployment of IRS, ITN, and LLIN with the use of
strong stratification criteria has resulted in high coverage
of targeted populations most at-risk, contributing to the
downward trend in incidence [6,24]. Global Fund grant
support increased access to these prevention measures.
In order to maintain the progress of the last decade,
Bhutan must address the challenges it faces to eliminate
malaria. The increase in cases that occurred from 2008 to
2009 is an indicator that there is still more work to be
done. Further studies on understanding mosquito vectors
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and their bionomics are warranted in order to formulate
more specific intervention strategies. The Malaria Techni-
cians deployed by the VDCP are a pillar of the programme
and must be maintained in order to ensure vigilance and
timely response. The integration of duties of Malaria
Technicians could potentially lead to a weakened response
to malaria outbreaks and this must be avoided. Increases
in transmission across the southern border in Assam or
West Bengal, India may directly impact transmission in
southern Bhutan [24]. Adding to the risk is the continual
migration into Bhutan from these states, regulated and
unregulated and daily and long-term, which may continu-
ally reintroduce infections into all receptive areas of the
country [7]. A clear understanding of the origin and path-
ways of migrants into Bhutan would facilitate the develop-
ment of effective strategies to mitigate and manage
imported malaria and the risk of onward transmission.
Limitations
This case study is based on a retrospective analysis of
national surveillance data on confirmed malaria infections.
The number of unconfirmed cases is not known, yet the
relatively high level of access to public health facilities and
lack of private sector facilities translates to a negligible
level of unconfirmed infections. The epidemiology data
does not allow for a more extensive analysis of the malaria
infection of long-term migrant workers in Bhutan.
National case investigation procedures have not collected
enough information to identify the origin of infection, but
will attempt to do so in the future.
Conclusions
Bhutan has made great strides towards elimination. The
greatest challenge to this goal is in identifying and contain-
ing imported infections from the neighbouring Indian
states. The malaria programme has identified two main
approaches to face this problem. Firstly, implement border
screening and secondly, develop cross-border and regional
malaria collaborations [7]. A recent WHO report recom-
mends border post screening for malaria not only to iden-
tify and treat infections, but also to install a way to
measure increases in transmission in order to adequately
prepare response measures [36]. Overall, though, evidence
is lacking on the impact of border screening, with only a
few available examples, most from island contexts which
are obviously very different than landlocked Bhutan. The
Thailand-Cambodia artemisinin resistance containment
project has included mobile malaria clinics at border
crossings in Thailand, but this activity has not been
assessed for impact on transmission reduction [39]. Recent
research on a passenger screening surveillance programme
in Mauritius [40] and the acceptability of inter-province
port screening in Solomon Islands [41] provides some
examples of identification of imported malaria infections,
but more research is needed. In Bhutan, where borders are
porous and migrant populations pass daily over the bor-
der, other measures may be needed in addition to the bor-
der screening centers, which target longer-term migrant
workers. Regional or cross-border initiatives may be an
important tool to lower importation risk [1,7]. Harmo-
nized surveillance, case management and vector control
strategies and their synchronized implementation in bor-
der regions are generally successful through a multi-coun-
try platform. Yet the history of cross-border collaboration
between Bhutan and India attests to the challenge of
developing such an initiative, from getting the key partners
to the table to finding sustainable funding support. The
cancellation of Rounds 11 and 12 by the Global Fund
speaks to the latter challenge. As more countries near
elimination, regional approaches, backed by sound evi-
dence and supported with adequate funding, are likely to
be the way forward.
Additional material
Additional file 1: Webappendix. A Literature Review on Malaria Control
and Elimination in Bhutan.
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